AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

The first international guidance on antithrombotic therapy in the elderly came from the
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …

Background Device-related thrombus (DRT) has been considered an Achilles' heel of left
atrial appendage occlusion (LAAO). However, data on DRT prediction remain limited …

Objectives This study sought to report early experience with the new-generation Watchman
FLX device (Boston Scientific, Marlborough, Massachusetts). Background The new …

Abstract Background and Aims Residual leaks are not infrequent after left atrial appendage
occlusion. However, there is still uncertainty regarding their prognostic implications. The aim …

Background: Device-related thrombosis (DRT) following left atrial appendage occlusion is a
rare but feared complication. The diagnostic value of cardiac compute tomography (CT) for …

The field of left atrial appendage occlusion is rapidly evolving. However, several issues
remain including the limited randomized efficacy data, peri-device leak, device-related …

Background Device-related thrombus (DRT) remains one of the main concerns after left
atrial appendage occlusion (LAAO). Several risk factors have been proposed, but most …

Thrombus formation on intracardiac devices remains a subject of importance, with rates in
the 2-5% range. Device-related thrombus (DRT) following left atrial appendage occlusion is …

Transcatheter left atrial appendage (LAA) closure is an alternative to long-term
anticoagulation therapy in selected patients with nonvalvular atrial fibrillation who have an …